Start with its own history
At 19.09×, FONR is 91.5% above its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NASDAQ · FONRMedical - Equipment & ServicesUpdated Oct 27, 2026
Fonar Corp. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
19.09×
91.5% abovethe 10-year annual average
Share price19.09
÷Earnings per share1
Price and EPS in quote currency. Calculation details
Investors are paying 19.09 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 9.97×
3-year average11.63×3 positive annual observations
5-year average11.09×5 positive annual observations
10-year average9.97×10 positive annual observations
Peer median · TTMN/M0 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2025 | 11.87× | +14.8% |
| Jun 30, 2024 | 10.35× | -18.3% |
| Jun 30, 2023 | 12.67× | +48.4% |
| Jun 30, 2022 | 8.53× | -29.0% |
| Jun 30, 2021 | 12.03× | +0.7% |
| Jun 30, 2020 | 11.94× | +77.3% |
| Jun 30, 2019 | 6.73× | -14.3% |
| Jun 30, 2018 | 7.86× | -15.6% |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2017 | 9.31× | +11.1% |
| Jun 30, 2016 | 8.38× | +58.5% |
| Jun 30, 2015 | 5.29× | -29.8% |
| Jun 30, 2014 | 7.53× | +62.2% |
| Jun 30, 2013 | 4.64× | +5.3% |
| Jun 30, 2012 | 4.41× | +26.0% |
| Jun 30, 2011 | 3.50× | N/M |
| Jun 30, 2010 | N/M | N/M |
| Jun 30, 2009 | 9.05× | N/M |
| Jun 30, 2008 | N/M | N/M |
| Jun 30, 2007 | N/M | N/M |
| Jun 30, 2006 | N/M | N/M |
| Jun 30, 2005 | 120.00× | N/M |
| Jun 30, 2004 | N/M | N/M |
| Jun 30, 2003 | N/M | N/M |
| Jun 30, 2002 | N/M | N/M |
| Jun 30, 2001 | N/M | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How FONR compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 FONR This stockFonar Corp. | 19.09× |
 HYPRHyperfine, Inc. | N/M |
 VANIVivani Medical, Inc. | N/M |
 NSPRInspireMD, Inc. | N/M |
 RCELAvita Medical Inc. | N/M |
 QIPTQuipt Home Medical Corp. | N/M |
 EDAPEdap Tms S.a. | N/M |
 ARTVArtiva Biotherapeutics, Inc. | N/M |
 APYXApyx Medical Corporation | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does FONR’s P/E tell you?
Compare like with like
Peer ratios add context to the company's own history. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take FONR into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("FONR", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 19.09 ÷ EPS 1 = 19.09×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Oct 27, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
FONR P/E ratio: common questions
The essentials behind the numbers.
Fonar Corp.'s current P/E is 19.09× based on the quote data last updated Oct 27, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.